Recently, Elanco marked a significant milestone at its Huningue, France site by breaking ground on a 5,000 sq/m site expansion project. The site specializes in tablet production, so this expansion will help meet increased product demand and support the production of Elanco’s latest innovations, helping pets live longer healthier lives.

Elanco is one of only two Animal Health companies that manufactures products in all four Pet Health categories—parasiticides, dermatology, pain, and vaccines. The Huningue, France site manufactures three of these four categories. Over the past several years, the site has been expanding to further enable Elanco’s ability to support product innovation for its pet health customers around the world.

This project includes:

  • 750 square meters of new production space
  • Expanded storage capacity
  • Additional quality control space
  • 50 new positions, representing a 20% workforce growth at the site.

Celebrating this moment were Jared Inman, Site Director, Paul Riga, DVM, eMBA, President of Elanco France, Grace McArdle, Executive Vice President – Manufacturing, Frederic Rohmer, Vice President Manufacturing small Molecules, as well as elected officials from the Grand Est region and all the 230 employees of the site.

VERO BEACH, Fla., April 4, 2025 /PRNewswire/ — Frederick “Derick” Cooper, CEO of QOL Medical, continues to make a lasting impact across multiple communities through a series of charitable donations aimed at supporting religious organizations and their missions. Over the past two years,…

Two presentations in the General Neurology and Late Breaker sessions will respectively cover new clinical and microRNA data from NeuroSense CAMBRIDGE, Mass., April 4, 2025 /PRNewswire/ — NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN), a leading clinical-stage biotechnology company focused…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.